Terms: = Colorectal cancer AND HOXD13, SPD, 3239, P35453, HOX4I AND Treatment
14 results:
1. The use of colonic stents as a bridge to surgery in malignant colonic obstruction - A dual trust experience over 10 years.
Canny JD; Johnston DB; McBrearty JA; McElvanna K; Caddy G; McKay D
Ulster Med J; 2024 Jan; 92(3):134-138. PubMed ID: 38292498
[TBL] [Abstract] [Full Text] [Related]
2. Clinical, Functional, and Nutritional Efficacy of a Glutamine-Enriched Oligomeric Diet in Patients with Rectal cancer.
Peña Vivas JDC; Orduz Arena AC; Alonso García A; Carrascal Gordillo CF; Martínez Gutiérrez R; Rodríguez-Acosta Caballero C; Fernández Freije I; Paino Martínez AB; Belloso Cuesta T; Juan Rijo G; Calleja Fernández A
Nutr Cancer; 2024; 76(1):128-136. PubMed ID: 37994411
[TBL] [Abstract] [Full Text] [Related]
3. GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of colorectal cancer.
Huntington KE; Louie AD; Srinivasan PR; Schorl C; Lu S; Silverberg D; Newhouse D; Wu Z; Zhou L; Borden BA; Giles FJ; Dooner M; Carneiro BA; El-Deiry WS
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446056
[TBL] [Abstract] [Full Text] [Related]
4. Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer.
He Y; Zhang X; Zhu M; He W; Hua H; Ye F; Zhou X; Chen N; Li Y; Zhong W; Wu G; Cai H; Jiang W
J Transl Med; 2023 Jan; 21(1):25. PubMed ID: 36639643
[TBL] [Abstract] [Full Text] [Related]
5. Protective Role of Spermidine in Colitis and Colon Carcinogenesis.
Gobert AP; Latour YL; Asim M; Barry DP; Allaman MM; Finley JL; Smith TM; McNamara KM; Singh K; Sierra JC; Delgado AG; Luis PB; Schneider C; Washington MK; Piazuelo MB; Zhao S; Coburn LA; Wilson KT
Gastroenterology; 2022 Mar; 162(3):813-827.e8. PubMed ID: 34767785
[TBL] [Abstract] [Full Text] [Related]
6. hoxd13 promotes the malignant progression of colon cancer by upregulating PTPRN2.
Yin J; Guo Y
Cancer Med; 2021 Aug; 10(16):5524-5533. PubMed ID: 34272834
[TBL] [Abstract] [Full Text] [Related]
7. Feasibility of Fitness Tracker Usage to Assess Activity Level and Toxicities in Patients With colorectal cancer.
Ward WH; Meeker CR; Handorf E; Hill MV; Einarson M; Alpaugh RK; Holden TL; Astsaturov I; Denlinger CS; Hall MJ; Reddy SS; Sigurdson ER; Dotan E; Zibelman M; Meyer JE; Farma JM; Vijayvergia N
JCO Clin Cancer Inform; 2021 Jan; 5():125-133. PubMed ID: 33492994
[TBL] [Abstract] [Full Text] [Related]
8. [Selection of Chemotherapy Regimen on the Basis of Monitoring NLR and Soluble PD-L1 during CRC Chemotherapy].
Muneoka K; Shirai Y; Sasaki M; Honma S; Sakata J; Kanda J; Wakabayashi H; Wakai T; Miyazaki M
Gan To Kagaku Ryoho; 2018 Aug; 45(8):1159-1163. PubMed ID: 30158411
[TBL] [Abstract] [Full Text] [Related]
9. Surgical resection and peri-operative chemotherapy for colorectal cancer liver metastases: A population-based study.
Booth CM; Nanji S; Wei X; Biagi JJ; Krzyzanowska MK; Mackillop WJ
Eur J Surg Oncol; 2016 Feb; 42(2):281-7. PubMed ID: 26558526
[TBL] [Abstract] [Full Text] [Related]
10. Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma.
Thompson PA; Wertheim BC; Zell JA; Chen WP; McLaren CE; LaFleur BJ; Meyskens FL; Gerner EW
Gastroenterology; 2010 Sep; 139(3):797-805, 805.e1. PubMed ID: 20538001
[TBL] [Abstract] [Full Text] [Related]
11. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
; Gray R; Barnwell J; McConkey C; Hills RK; Williams NS; Kerr DJ
Lancet; 2007 Dec; 370(9604):2020-9. PubMed ID: 18083404
[TBL] [Abstract] [Full Text] [Related]
12. Effects of N1, N13-diethylnorspermine (DENSPM) and X-radiation treatment on human colorectal tumor clones with varying X-radiation and drug responses.
Qutob SS; Proulx D; Mesak FM; Ng CE
Radiat Res; 2005 Apr; 163(4):357-63. PubMed ID: 15799689
[TBL] [Abstract] [Full Text] [Related]
13. Troxacitabine: BCH 4556, spd 758, Troxatyl.
Adis International Ltd
Drugs R D; 2003; 4(4):264-8. PubMed ID: 12848594
[TBL] [Abstract] [Full Text] [Related]
14. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
[TBL] [Abstract] [Full Text] [Related]
